Oxford BioDynamics: 3Ds to Success

Oxford BioDynamics (LSE:OBD) is a 3D genomics company and provides updates on operations for FY September 2026 and on its strategy to generate revenue from Discovery, Development and Diagnostics. Its AI-powered 3D genomics discovery platform transforms standard and legacy whole genome sequencing datasets into discovery insights in hours rather than months. Around 4,200 of the EpiSwitch PSE diagnostic tests were sold in the year, representing an increase of 124%, and revenue of £1.65m is in line with market expectations. The current run-rate is more than double, with a further record monthly or...

Latest News

More Articles Like This